This article was originally published in The Gray Sheet
FDA market go-ahead for the Ortho Summit system and processor makes it "the first automated system for blood and plasma screening cleared by the FDA," Cotelligent maintains. Developed in conjunction with Ortho Clinical Diagnostics, the system is designed to screen blood products for hepatitis and retroviruses, including HIV and HTLV. Initial installations are anticipated by year-end
You may also be interested in...
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.
The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.
The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.